Robert Klein

Robert is a business development professional with over two decades experience in the biotechnology, diagnostics, and genomics spaces. He has spent half his career working in neuroscience drug development as both a scientist and a BD professional. Most recently, Robert served as Chief Business Officer at Complete Genomics. Prior to that, Robert held positions of CEO at iKaryos Diagnostics, CSO at Amnestix, Sr. Director BD at Rinat Neuroscience, and VP of Business and Technology Development at Deltagen and played an integral role with each of these company‚Äôs M&A or IPO activities . Robert started his career at Genentech where he was a post doc and scientist in the Neuroscience Department. Robert obtained his PhD in biology from MIT and his A.B. in biochemistry from UC Berkeley.